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into knee joints at various time-points after induction of OA. OA
phenotypes were measured within 8 weeks after induction. Total knee
joints were isolated and processed for histology. Synovial activation was
measured using an arbitrary scale (0 to 3) and cartilage destruction was
measured in 4 different layers of the knee joint (medial and lateral tibia
and femur) according to the scoring method of Pritzker et al.. Moreover,
damage to the cruciate ligaments was scored using an arbitrary scale
(0 to 5).
Results: After culture FACS analysis showed that the adherent fraction
expressed characteristic markers for stem cells (positive staining for
Sca-1, CD-44 and CD-105 and negative staining for CD-11b and cKIT).
Using RT-PCR, we found that ASCs expressed high mRNA levels of TIMP
1, 2 and 3 but not TIMP 4. A single dose of ASCs (20×103in mouse
serum) was injected into the knee joint of mice, 7 days after induction
of osteoarthritis. Synovial activation was signiﬁcantly inhibited at day
14 (9%) and day 42 (35%) when compared to serum treated joints.
Destruction of cartilage was also signiﬁcantly inhibited at day 14 (54%)
and at day 42 (35%). Inhibition of cartilage destruction was particularly
found in the medial tibia. Interestingly, ASC-treatment had a protective
effect on the cruciate ligaments. At day 42, damage to the ligaments
was reduced by nearly 50% in the ASC treated joints when compared
to controls. In line with that, 87.5% of the control animals showed a
dislocation of the knee joint, whereas only 25% of the ASC treated
animals. In contrast to early treatment, injection of the same dose of
ASCs, 14 days after induction of OA only showed a small inhibiting effect
(11%) on synovial activation when measured at day 42. Although cartilage
destruction diminished with 28%, these values did not reach signiﬁcance
at that time-point.
Conclusions: Our study indicates that a single injection of ASCs into
the knee joints of mice with collagenase-induced osteoarthritis gives
protection of synovial activation and cartilage destruction when given
shortly (day 7) after induction of experimental OA, possibly by inhibiting
MMP activity and protection of damage to cruciate ligaments.
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BETA-XYLOSIDES INHIBITION OF CHONDROITIN SULPHATE
SUBSTITUTION ON MATRIX PROTEOGLYCANS PERTURBS THE
DIFFERENTIATION OF BONE MARROW STEM CELLS INTO A
CHONDROGENIC LINEAGE
S. Li, B. Caterson, A.J. Hayes, C.E. Hughes. Sch. of BioSci.s, Cardiff Univ.,
Cardiff, United Kingdom
Purpose: In a previous study (Hayes et al. J Histochem Cytochem.
2007, 56: 125–138) we reported that novel chondroitin sulphate (CS)
sulphation motifs on cell-associated proteoglycans (PGs) may be putative
biomarkers of progenitor/stem cell sub-populations (Dowthwaite et al.
J Cell Sci. 2005, 117: 889–897). Recent studies indicate that unique CS
sulphation motifs are localized in putative stem/progenitor cell niches
at sites of incipient articular cartilage & other musculoskeletal tissues,
which indicates their potential importance in cell differentiation during
development. In this study, we investigated the importance of CS chains
in the differentiation of bone marrow stem cells to the chondrogenic
phenotype in vitro using p-nitrophenyl xyloside (PNPX) as a competitive
inhibitor of CS substitution on matrix PGs.
Methods: Bovine bone marrow stem cells (BMSCs) were isolated
from 7-day-old cow legs and cultured as monolayer for 4 weeks
with chondrogenic medium ± 0.25mM PNPX. At each week, samples
were analysed for sulphated glycosaminoglycans (sGAG), real-time PCR,
Western Blotting & immunohistochemistry (IHC) using monoclonal
antibodies recognising native and enzyme-generated epitopes &
neoepitopes. The expression and distribution of structural chondroitin
sulphation proteoglycans (CS-PGs) were analysed by immunoﬂuorescent
staining combined with confocal microscopy scanning.
Results: BMSCs cultured in chondrogenic medium start to aggregate
and form mini-cell beads in 3 days and these mini cell beads clustered
together to form a large cartilaginous cell bead in 2–4 weeks. There
was no structural CS-PGs expression including aggrecan, biglycan &
decorin when cells remained as monolayer. However, these CS-PGs
were observed as long as the cells form mini-cell beads, suggesting
an initiation of chondrogenic process. BMSCs cultured with 0.25mM
PNPX still form the mini-cell beads and the single cartilaginous cell
bead although it is 3–5 days later when compared with the control.
This indicated that PNPX delayed the cell clustering and bead formation,
a key milestone during the chondrogenic differentiation process. Real-
time PCR and Western blotting results indicated that PNPX signiﬁcantly
inhibited or delayed the expression of chondrogenic markers such as
aggrecan, SOX-9 & type II collagen gene and/or protein expression,
suggesting the delay or inhibition of chondrogenic process. Interestingly,
using monoclonal antibodies 7D4 and 6C3 identifying different epitopes
along CS chains, we found that PNPX did not alter 7D4 staining but
completely deplete the expression of 6C3 epitopes at the early stage
of culture (1 week). Confocal microscopy analysis indicated that there
was a colocalisation between 7D4 and aggrecan as well as biglycan
core protein in the extracellular matrix of mini-cell bead after 2 weeks
culture with or without PNPX. Differently, the colocalisation between
6C3 and biglycan was disrupted by PNPX, and there was no apparent
colocalisation between 6C3 and aggrecan core protein. After 4 weeks of
culture, 7D4 staining was observed across the cartilaginous-like bead and
there was no difference between control and PNPX group. 6C3 staining
was also evident across the whole bead in the control group. However,
it was absent on the surface of the bead cultured with PNPX. Taken
together, this highlight that different composition of CS chains may play
distinct roles in the chondrogenic differentiation, and 6C3 epitopes are
more important than 7D4 during bMSCs chondrogenesis.
Conclusion: These results indicated that CS sulphation motifs may play
an important role in BMSCs differentiation into chondrogenic lineages.
Its precise mechanism is not clear yet, but CS sulphation motifs may
be involved in the cell aggregating, the initiation of chondrogenic
process and extracellular matrix-cell interaction during the whole
chondrogenesis.
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DOES ACOUSTIC HOMOGENEITY CORRELATE WITH TISSUE QUALITY
IN ENGINEERED CARTILAGE?
J.F. Welter, M. Citak, H. Baskaran, A.I. Caplan, V.M. Goldberg,
J.M. Mansour. Case Western Reserve Univ., Cleveland, OH, USA
Purpose: Osteoarthritis related cartilage defects affect a large and
growing fraction of the population. As cartilage does not self-repair,
these defects present a long term problem; the end-point is usually total
joint replacement. Patching these defects with living tissue-engineered
(TE) tissue, particularly based on mesenchymal stem cells (MSCs),
is being considered as an approach to avoid or delay arthroplasty.
In this approach, biocompatible scaffolds are seeded at high density
with MSCs and then exposed to a chondroinductive medium in vitro.
Despite uniform initial conditions, the engineered cartilage develops in
a centripetal fashion. After several weeks in culture, there is a wide range
of possible outcomes. The best case results in solid cartilage specimens
being generated, the worst in a cartilage shell of varying thickness
surrounding an immature soft center. From the outside, without resorting
to histological evaluation, these extremes appear visually identical. This
study is a proof-of-concept of the use of an inexpensive, non-imaging,
ultrasound system to assess the internal homogeneity of TE cartilage
samples by non-destructive testing.
Methods: Deidentiﬁed hMSCs were obtained from three healthy
volunteer donors under the terms of an IRB approved protocol. The
cells were culture-expanded until the end of 1st ﬁrst passage and
were then seeded at 8×108 cells/ml onto 6mm diameter × 3mm
thick macroporous collagen-chondroitin sulfate scaffolds with different
formulations. The cell-seeded constructs were then grown for up to
3 weeks in a perfusion bioreactor. In parallel, calf stiﬂe joints were
obtained from a local abattoir; the cartilage was shaved off and 6mm
diameter disks were then punched out using a biopsy punch. The normal
cartilage disks or the engineered tissue were immersed in buffered saline.
A Panametrics V116-RM ultrasound transducer was mounted in a custom
jig and positioned at 90° to the surface of the test sample. A Panametrics
5072PR pulser-receiver and a Picoscope 3206 oscilloscope were used to
capture the ultrasound data, after which the test samples were processed
for histology.
Results: In normal bovine cartilage, clear acoustic reﬂections were
obtained from the front and rear faces of the biopsy, and very few internal
reﬂections were found. This correlates well with the homogeneous
histological aspect of the native cartilage plugs. In the engineered
tissue, in addition to the front and rear faces of the sample, numerous
internal reﬂections of comparable magnitude could be found. Histological
examination of the engineered tissue samples showed an irregular
differentiated shell surrounding an undifferentiated cellular core. Thus,
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while the native tissue was visually and acoustically homogeneous, the
engineered tissue contains structural discontinuities which correlate well
with the acoustic discontinuities.
Fig. 1. Reﬂections from the front and rear faces of native bovine
cartilage (A) or tissue engineered cartilage (B). In contrast to the native
tissue, there are numerous reﬂections in the engineered tissue.
Conclusions: We have previously shown that speed of sound
measurements can be used to estimate actual mechanical properties
of hydrogels and are working to extend these ﬁndings to cartilage.
The present proof of concept work suggests that ultrasound can
also be used to assess, in a non-contact, non-destructive fashion the
internal homogeneity of growing TE cartilage. We thus suggest that
acoustic homogeneity of engineered tissue is a useful predictor of tissue
homogeneity and thus can be used as a further quality control measure.
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ENGINEERING MURINE STEM CELL DERIVED BONE AND CARTILAGE
IN NOVEL BIOMIMETIC BIOREACTOR
P. Lee, D. Rancourt, R. Krawetz. Univ. of Calgary, Calgary, AB, Canada
Purpose: Research in bone and cartilage engineering for regenerative
medicine approaches has expanded over the last decade; however,
few methods have been clinically translated. Partially because most
engineered constructs lack anatomical and mechanical characteristics
of native tissues, and can be resorbed after implantation. In this study,
we have derived an engineered bone and cartilage construct (EBCC)
that is collagen based; within a novel biomimetic bioreactor. Previous
results from our lab demonstrated collagen 1 and chondroitin sulphate
to be potent inducers for osteogenesis and chondrogenesis respectively.
However, prolonged maintenance cell viability and application of
mechanical stimulants remains a hurdle in static tissue culture setting.
Hence, a novel bioreactor system capable of emulating physiological
environment speciﬁc for bone and cartilage development was designed;
to enhance potential of the EBCC to possess both anatomical and
mechanical resemblance to tissue in physiology.
Methods: A perfusion bioreactor was designed to provide continual
ﬂow of media to the EBCC at constant ﬂow rate. The design allows
alternation of media compositions in real-time, based on the needs
of the EBCC at each stage of differentiation with minimal disruptions.
An isolated polymerized collagen 1 platform was fabricated within
the bioreactor to support embryonic stem cells (ESC) differentiation.
Nutrients and oxygen gradients developed within the bioreactor are
based on the design of bioreactor and seeding density of ESCs. This
gradient is exploited (with media supplementation) to promote both
osteogenesis and chondrogenesis at different parts of the platform;
resulting in EBCC formation. Furthermore, the materials used to assemble
the bioreactor are amenable to direct mechanical stimulation (bending
and compression) and is applied to the developing EBCC to enhance
differentiation.
Results: Cells in EBCC remained viable for at least 45 days post
inoculation, with extensive cellular remodelling observed. A construct
with ﬁrm structural features was developed. Quantitative PCR (qPCR)
analyses demonstrated signiﬁcant decrease in pluripotent marker, OCT-4,
after 30 days, with coinciding increases in osteogenic and chondrogenic
markers.
Conclusions: This novel bioreactor promotes long term cultivation and
differentiation of the EBCC. Using the cast and mould concept, we
had established an EBCC with speciﬁc shape, that retains mechanical
properties after removal from the bioreactor. In future experiments we
will be applying various mechanical stimulants on the EBCC to drive
further maturation and transplant the construct into critical size skeletal
defects. The EBCC principle, once validated in vitro and in vivo holds
promises as an alternative approach for producing custom implants that
can contain both bone and cartilage components.
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EFFECT OF SYNOVIAL FLUID ON THE IMMUNOMODULATORY
CAPACITY OF MESENCHYMAL STEM CELLS
M.J. Leijs, G.M. van Buul, N. Kops, W.L. Koevoet, E. Lubberts, J.A. Verhaar,
M.J. Hoogduijn, G.J. van Osch. Erasmus MC, Rotterdam, Netherlands
Purpose: Mesenchymal stem cells (MSCs) are promising candidates
for cell therapeutic application in osteoarthritis (OA) and rheumatoid
arthritis (RA). The catabolic environment in joints of OA and RA patients
results in progressive joint damage. MSCs can have anti-catabolic or
anti-inﬂammatory effects by secreting anti-inﬂammatory cytokines and
growth factors. In order to become immunosuppressive MSCs need to be
triggered by for instance pro-inﬂammatory cytokines. We hypothesized
that synovial ﬂuids inﬂuences the immunomodulatory effects of MSCs
and investigated this in vitro by analyzing the gene expression of
immunomodulatory factors.
Methods: Human bone marrow derived MSCs were cultured in
monolayer in serum-free medium with 1% ITS with or without 20%
synovial ﬂuid for 48 hours. Synovial ﬂuid of six OA donors, six RA
donors and three healthy donors were used in triplicate cultures. Gene
expression of immunoregulatory cytokines IL-6, HGF, TNFa, TGFb1 and
